BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2014
View Archived Issues
Initial report on first-in-human study of 3-V Bioscience's TVB-2640
Read More
Valaciclovir approval expanded in Japan
Read More
FDA grants orphan drug status to vatiquinone for Rett syndrome
Read More
New murine models to study human hepatitis viral infection described at AASLD meeting
Read More
Transition Therapeutics reports results from ELND-005 study
Read More
Apellis to acquire Potentia Pharmaceuticals
Read More
Sanquin and Okklo collaborate to develop cyclodextrins for cardiovascular indications
Read More
Karus Therapeutics patents novel HDAC6 inhibitors
Read More
Nimbus Apollo reports new ACC2 inhibitors
Read More
SOM Biotech and Vall d'Hebron begin trial of repositioned drug for amyloidosis
Read More
New GABA(A) receptor agonists disclosed by Sichuan Haisco
Read More
MetrioPharm files IND application for immunomodulator MP-1032
Read More
A genetically attenuated P. falciparum as vaccine candidate
Read More
Cosentyx receives positive CHMP opinion for first-line treatment of psoriasis
Read More
Nintedanib obtains positive opinion in European Union for the treatment of IPF
Read More
Palovarotene receives EMA orphan medicinal product designation
Read More
In vivo protection with inactivated dengue virus antigens plus alphavirus adjuvant
Read More
EMA gives positive opinion for hepatitis C therapy Viekirax plus Exviera
Read More
Pharmacological profile of a novel PDE10A inhibitor, MT-3014
Read More
CHMP adopts positive opinion for Genzyme's Cerdelga
Read More
Studies compare time to ESRD in aHUS patients treated with supportive care or eculizumab
Read More
Kissei Pharmaceutical discloses new TRPM8 antagonists
Read More
Galapagos patents novel CFTR activators
Read More
European Commission approves Duaklir Genuair for COPD
Read More
CHMP backs Otezla for psoriasis and psoriatic arthritis
Read More
Signifor approved in E.U. to treat acromegaly
Read More